Compliance With Secondary Prevention of Ischemic Stroke | Zendy

Tanja Sappok | Zendy; Andreas Faulstich | Zendy; Erika Stuckert | Zendy; Holger Kruck | Zendy; Peter Marx | Zendy; HansChristian Koennecke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Compliance With Secondary Prevention of Ischemic Stroke

Author(s) -

Tanja Sappok,

Andreas Faulstich,

Erika Stuckert,

Holger Kruck,

Peter Marx,

HansChristian Koennecke

Publication year - 2001

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.32.8.1884

Subject(s) - medicine , antithrombotic , hyperlipidemia , stroke (engine) , diabetes mellitus , risk factor , fibrinolytic agent , logistic regression , physical therapy , mechanical engineering , engineering , endocrinology

Compliance with pharmacological therapy is essential for the efficiency of secondary prevention of ischemic stroke. Few data exist regarding patient compliance with antithrombotic and risk factor treatment outside of controlled clinical trials. The aim of the present study was to assess the rate of and predictors for compliance with secondary stroke prevention 1 year after cerebral ischemia and to identify reasons for noncompliance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research